SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Biogen Says Diranersen Slowed Clinical Decline 38% at Two Years

Diranersen slowed clinical decline by 38% on CDR-SB at Week 96, according to the report.

BIIB

Related stories